Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Estrogen Receptor Variants, HDL, and Atherosclerosis

NCT00081705 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.

NCT NCT00081705
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00081705 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Estrogen Receptor Variants, HDL, and Atherosclerosis
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Phase
Observational
Overall status
Completed
Start date
March 31, 2004
Completion date
February 28, 2007
Enrollment
Not reported
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, cardiovascular diseases, coronary arteriosclerosis, heart diseases